Factors Increasing Lung Cancer Risk in Never-Smoking Women
This observational study aims to identify factors associated with an increased risk of non-small cell lung cancer (NSCLC) in women who have never smoked, using demographic assessments and whole-exome sequencing.
Data Collection
+ other Data
Collected from today forward - ProspectiveLung Diseases+4
+ Neoplasms
+ Neoplasms by Site
Case-Control
Comparing exposures between individuals with and without disease in order to identify potential risk factors.Summary
Study start date: June 30, 2026
Actual date on which the first participant was enrolled.This study focuses on understanding factors that might increase the risk of lung cancer in individuals who have never smoked, specifically women. The goal is to gather insights that could help predict which non-smoking individuals may have a higher likelihood of developing lung cancer. This research is important as it aims to address the unique challenges of lung cancer in never-smokers, a group often overlooked in traditional lung cancer research.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.500 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Case-Control
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 40 to 74 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Criteria: * Female at birth * Age 40-74 years * No smoking history * Participants must be never-smokers, defined as having smoked \<100 cigarettes in their lifetime * Documentation of disease - case patients o Case patients must have pathologically confirmed primary lung adenocarcinoma. New and prevalent cases will be eligible. Case patients with a history of prior non-lung cancer will be eligible for the study unless actively being diagnosed or treated for another form of cancer at the time of enrollment. * Criteria for control participants * Control participants must have no personal history of lung cancer, symptoms suspicious for lung cancer, or suspicious pulmonary nodules. Participants recruited as controls and found on imaging to have lesions suspicious for lung cancer will be excluded from analysis and followed prospectively. Data regarding these participants will be reported in a sensitivity analysis. Additional control participants will be recruited to ensure balanced age- and race-matched enrollment by frequency matching. Control participants with a history of prior non-lung cancer will be eligible for the study unless actively being diagnosed or treated for another form of cancer at the time of enrollment.
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 7 locations
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Basking Ridge, United StatesOpen Memorial Sloan Kettering Basking Ridge (All Protocol Activities) in Google MapsMemorial Sloan Kettering Monmouth (All Protocol Activities)
Middletown, United StatesMemorial Sloan Kettering Bergen (All Protocol Activities)
Montvale, United StatesMemorial Sloan Kettering Suffolk - Commack (All Protocol Activities)
Commack, United States